Skip to main content

Articles

Page 1 of 78

  1. To explore the associations of computed tomography (CT) image features with the serum cryptococcal antigen (CrAg) titers measured by the lateral flow assay (LFA) in localized pulmonary cryptococcosis patients.

    Authors: Chunmei Dai, Dongyu Bai, Chunbei Lin, Ke-Yi Li, Wenliang Zhu, Juan Lin, Fang Lu, Qiujuan Chen, Wen Luo, Bo Zhu and Yihua Lin
    Citation: BMC Pulmonary Medicine 2024 24:441
  2. Recurrent respiratory infections are a leading cause of morbidity and mortality in persons with Cystic Fibrosis (pwCF). Recently, the emergence of Nocardia species as a potential pathogen in CF has raised ques...

    Authors: Vito Terlizzi, Tommaso Ballerini, Alice Castaldo, Daniela Dolce, Silvia Campana, Giovanni Taccetti and Elena Chiappini
    Citation: BMC Pulmonary Medicine 2024 24:440
  3. A 3.0-mm ultrathin bronchoscope (UTB) with a 1.7-mm working channel provides better accessibility to peripheral bronchi. A 4.0-mm thin bronchoscope with a larger 2.0-mm working channel facilitates the use of a...

    Authors: Xinying Sun, Hui Chen, Sha Li, Xuechan Yu, Ruyi Xu, Lin Zheng, Dan Lv, Xiaoyan Jin, Yan Zhang, Hongying Ma, Zaichun Deng, Yiming Yu and Zhongbo Chen
    Citation: BMC Pulmonary Medicine 2024 24:439
  4. Sustained lung inflation (SLI) right after birth to decrease the use of mechanical ventilation of preterm infants is controversial because of potential harm. This randomized controlled trial was conducted to e...

    Authors: Li-Ting Lu, Ya-Wen Chiu, Mei-Yin Su, Hsiu-Feng Hsiao, Mei-Chin Yang and Yi-Hao Weng
    Citation: BMC Pulmonary Medicine 2024 24:438
  5. Idiopathic Pulmonary Fibrosis (IPF) is a progressive fibrotic lung disease. However, the field of quantitative CT scan analysis in conjunction with pulmonary function test for IPF patients remains relatively u...

    Authors: Hongmei Zhang, Xinyi Li, Xiaoyue Zhang, Yu Yuan, Chenglei Zhao and Jinling Zhang
    Citation: BMC Pulmonary Medicine 2024 24:437
  6. Reports of pulmonary aspergillosis and mucormycosis co-infections are rare; thus, limited guidance is available on early diagnosis and treatment. We present a case of mixed pulmonary Aspergillus and Mucor infecti...

    Authors: Fei-Xiang Ling, Dong-Ming Qu, Ye-Quan Lu, Rou Li and Lei Zhao
    Citation: BMC Pulmonary Medicine 2024 24:436
  7. The causal relationships between testosterone, estradiol, estrogen sulfotransferase, and idiopathic pulmonary fibrosis (IPF) are not well understood. This study employs a bidirectional two-sample Mendelian Ran...

    Authors: Qingying Xu, Guangwang Hu, Qunying Lin, Menghang Wu, Kenan Tang, Yuyu Zhang and Feng Chen
    Citation: BMC Pulmonary Medicine 2024 24:435
  8. Phlegm is prevalent symptom in patients with chronic obstructive pulmonary disease (COPD). Few studies have investigated the effectiveness of N-acetylcysteine (NAC) nebulizer therapy in COPD patients. We evalu...

    Authors: Chin Kook Rhee, Seong Yong Lim, Won-Yeon Lee, Ji Ye Jung, Yong Bum Park, Chang Youl Lee, Yong Il Hwang, Jin Woo Song, Won-Il Choi, Kwang Ha Yoo, Ki Uk Kim, Yu-Il Kim, Tae-Hyung Kim, Seong Ju Park, Kyeong-Cheol Shin, Soo-Jung Um…
    Citation: BMC Pulmonary Medicine 2024 24:434
  9. Research studies typically quantify acute respiratory exacerbation episodes (AECOPD) among people with chronic obstructive pulmonary disease (COPD) based on self-report elicited by survey questionnaire. Howeve...

    Authors: Yorusaliem Abrham, Siyang Zeng, Wendy Lin, Colin Lo, Alexander Beckert, Laurel Evans, Michelle Dunn, Brian Giang, Krish Thakkar, Julian Roman, Paul D. Blanc and Mehrdad Arjomandi
    Citation: BMC Pulmonary Medicine 2024 24:433
  10. This study aimed to investigate the radiological changes in patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) having bronchiolitis patterns on computed tomography (CT).

    Authors: Sung Hyun Yoon, Hyung-Jun Kim, Jihang Kim, Junghoon Kim and Jae Ho Lee
    Citation: BMC Pulmonary Medicine 2024 24:432
  11. Previous studies have consistently reported a decrease in hospital admissions for respiratory diseases during the coronavirus disease 2019 (COVID-19) pandemic. However, the impact of the pandemic on idiopathic...

    Authors: In-So Cho, Jihye Lim, Min-Seok Chang and Ji-Ho Lee
    Citation: BMC Pulmonary Medicine 2024 24:430
  12. Patients with chronic lung diseases (CLDs), defined as progressive and life-limiting respiratory conditions, experience a heavy symptom burden as the conditions become more advanced, but palliative referral ra...

    Authors: Sheryl Hui-Xian Ng, Zi Yan Chiam, Gin Tsen Chai, Palvinder Kaur, Wan Fen Yip, Zhi Jun Low, Jermain Chu, Lee Hung Tey, Han Yee Neo, Woan Shin Tan and Allyn Hum
    Citation: BMC Pulmonary Medicine 2024 24:429
  13. Bronchial artery embolization (BAE) is currently an important treatment for hemoptysis. However, there is no consensus in the efficacy and safety of BAE compared to conservative treatment for hemoptysis, which...

    Authors: Shengxin Fan, Xiaocheng Cheng, Xiaohui Wang, Yuliang Liu, Wei He and Hong Chen
    Citation: BMC Pulmonary Medicine 2024 24:428
  14. Interstitial lung diseases (ILD) include a wide range of diseases impacting lung parenchyma and leading to fibrosis and architectural distortion. Chronic cough and dyspnea are common symptoms which affect the ...

    Authors: Eeva Saari, Minna Mononen, Hannele Hasala, Hanna Nurmi, Hannu-Pekka Kettunen, Sanna Suoranta, Elisa Lappi-Blanco, Riitta Kaarteenaho, Minna Purokivi and Heikki Olavi Koskela
    Citation: BMC Pulmonary Medicine 2024 24:427
  15. We evaluated the influence of different partial carbon dioxide pressure (PaCO2) levels on organ perfusion in patients with respiratory failure receiving pressure-support ventilation with veno-venous extracorporea...

    Authors: Yuankai Zhou, Liangyu Mi, Shengjun Liu, Yingying Yang, Na Cui, Xiaoting Wang, Huaiwu He and Yun Long
    Citation: BMC Pulmonary Medicine 2024 24:424
  16. With a series of clinical trials confirming the sensitivity of small cell lung cancer (SCLC) to immunotherapy, research on personalized treatment for SCLC has gained increasing attention. Currently, the most w...

    Authors: Jianan Li, Wentao Zhang, Yi Zhao, Jixian Li, Yuanliu Nie, Alei Feng, Qiang Li, Fengge Zhou, Renya Zeng and Zhe Yang
    Citation: BMC Pulmonary Medicine 2024 24:423
  17. In this study, we aimed to evaluate the clinical utility of Metagenomic Next-Generation sequencing (mNGS) on bronchoalveolar lavage fluid (BALF) in diagnosis of Lower Respiratory Tract Infections (LRTIs).

    Authors: Yanfen Zheng, Wei Liu, Tongyang Xiao, Hongtao Chen and Yan Liu
    Citation: BMC Pulmonary Medicine 2024 24:422
  18. Fractional exhaled nitric oxide (FeNO) is used for the diagnosis and monitoring of asthma, although its utility to guide treatment and its correlation with other tools is still under discussion. We study the p...

    Authors: Edwin Pesantes, Rosana Hernando, Carmen Lores, Jonathan Cámara, Elías Arévalo and Luis Lores
    Citation: BMC Pulmonary Medicine 2024 24:421
  19. Postoperative pulmonary complication (PPC) is a leading cause of mortality and poor outcomes in postoperative patients. No studies have enrolled intensive care unit (ICU) patients after noncardiac thoracic sur...

    Authors: Xiangjun He, Meiling Dong, Huaiyu Xiong, Yukun Zhu, Feng Ping, Bo Wang and Yan Kang
    Citation: BMC Pulmonary Medicine 2024 24:420
  20. Hemoptysis resulting from rupture of the pulmonary artery pseudoaneurysm (PAP) is massive and fatal, while factor contributing to the rupture of pseudoaneurysm remains elusive. This study aimed to elucidate th...

    Authors: Min Liu, Jixiang Liu, Wei Yu, Xiaoyan Gao, Shi Chen, Wei Qin, Ziyang Zhu, Chenghong Li, Fajiu Li and Zhenguo Zhai
    Citation: BMC Pulmonary Medicine 2024 24:417
  21. Pulmonary cryptococcosis (PC) is a common opportunistic fungal infection caused by Cryptococcus neoformans or Cryptococcus gattii. PC primarily invades the respiratory system, followed by the central nervous syst...

    Authors: Xiaofeng Bai, Hansheng Wang, Yijun Tang, Chuanyong Xiao, Yujie Gao, Hanmao Tong, Peipei Chen, Meifang Wang and Tao Ren
    Citation: BMC Pulmonary Medicine 2024 24:416
  22. The incidence of Pulmonary Hypertension (PH) and Pulmonary Arterial Hypertension (PAH) is believed to be on the rise and is associated with poor outcomes.

    Authors: Adam Hartley, Harpreet Singh, Chinmay Jani, Justin D. Salciccioli, Joseph Shalhoub, Luke S. Howard and Dominic C. Marshall
    Citation: BMC Pulmonary Medicine 2024 24:415
  23. Higher red blood cell distribution width (RDW) levels are associated with mortality in patients with chronic obstructive pulmonary disease (COPD). However, more convincing evidence is still lacking, and the re...

    Authors: Shanshan Liu, Hao Zhang, Panpan Zhu, Shiyu Chen and Zhihui Lan
    Citation: BMC Pulmonary Medicine 2024 24:413
  24. Ibuprofen is one of the most commonly used analgesic and antipyretic drugs in children. However, its potential causal role in childhood asthma pathogenesis remains uncertain. In this systematic review, we asse...

    Authors: Luke Baxter, Maria M. Cobo, Aomesh Bhatt, Rebeccah Slater, Olutoba Sanni and Nutan Shinde
    Citation: BMC Pulmonary Medicine 2024 24:412
  25. Albeit smoking cessation has unequivocal health benefits, attempts to quit are not unanimous, even in patient populations at high risk for smoking-related diseases cessation. Allelic variations of enzymes invo...

    Authors: Angela Mikaczo, Csaba Papp, Tamas Erdei, Aniko Posa, Gabor Zahuczky, Csaba Varga, Janos Szabo, Rudolf Gesztelyi, Maria Szilasi and Judit Zsuga
    Citation: BMC Pulmonary Medicine 2024 24:411
  26. Chronic thromboembolic pulmonary hypertension (CTEPH) is a type of pulmonary hypertension with a low incidence. Despite pulmonary endarterectomy(PEA) being the preferred treatment for CTEPH, for patients who f...

    Authors: Yuan Chen, Jialong Liang, Qian Li, Jintao Zhou, Jian Xu, Dian Xiong, Huachi Jiang, Shugao Ye and Jingyu Chen
    Citation: BMC Pulmonary Medicine 2024 24:410
  27. This study aimed to elucidate the causal relationship between Obstructive Sleep Apnea (OSA) and Chronic Respiratory Diseases (CRDs), employing Mendelian Randomization (MR) to overcome limitations inherent in o...

    Authors: Ping-Yang Hong, Dong Liu, Ang Liu, Xin Su, Xiao-Bin Zhang and Yi-Ming Zeng
    Citation: BMC Pulmonary Medicine 2024 24:409
  28. Available evidence suggests that adults with chronic obstructive pulmonary disease (COPD) performed substantially worse than healthy controls on many balance measures and balance training can improve the balan...

    Authors: Qiukui Hao, Dina Brooks, Cindy Ellerton, Roger Goldstein, Annemarie L. Lee, Jennifer A. Alison, Gail Dechman, Kimberley J. Haines, Samantha L. Harrison, Anne E. Holland, Alda Marques, Lissa Spencer, Michael K. Stickland, Elizabeth H. Skinner, Pat G. Camp, Jinhui Ma…
    Citation: BMC Pulmonary Medicine 2024 24:408
  29. For patients treated with osimertinib as first-line therapy, there have been no studies comparing both progression-free survival (PFS) and overall survival (OS) according to performance status (PS). Furthermor...

    Authors: Yoshihiko Taniguchi, Akihiro Tamiya, Mitsuo Osuga, Daijiro Harada, Shun-ichi Isa, Keiichi Nakamura, Yasuyuki Mizumori, Tsutomu Shinohara, Hidetoshi Yanai, Katsumi Nakatomi, Masahide Oki, Masahide Mori, Tomohito Kuwako, Koji Yamazaki, Atsuhisa Tamura, Masahiko Ando…
    Citation: BMC Pulmonary Medicine 2024 24:407
  30. Tuberculosis (TB) remains a global health challenge, with India bearing a significant burden. Despite advancements in TB diagnosis and treatment, monitoring TB treatment is challenging, particularly in resourc...

    Authors: Hamrish Kumar Rajakumar, Varsha Coimbatore Sathyabal, Arulkumaran Palaniyandi and Dakshinamurthy Balakrishnan
    Citation: BMC Pulmonary Medicine 2024 24:406
  31. Idiopathic pulmonary fibrosis (IPF), an interstitial lung disease, is characterized by the exacerbation of progressive pulmonary fibrosis (PF). IPF primarily affects older individuals and can lead to respirato...

    Authors: Xiaoshu Guo, Kai Xu, Qiwen Wang, Zongyuan Han and Guoying Yu
    Citation: BMC Pulmonary Medicine 2024 24:405
  32. The serum markers Krebs von den Lungen-6 (KL-6), surfactant protein A (SP-A), and surfactant protein D (SP-D) have been used for the diagnosis, differential diagnosis, and prognosis prediction of interstitial ...

    Authors: Kentaro Wakamatsu, Nobuhiko Nagata, Hiroyuki Kumazoe, Makiko Hara, Satomi Asai, Naotaka Noda, Ruriko Kiyotani, Izumi Fukui, Miyoko Tatsuta, Katsuyuki Katahira, Takashi Akasaki, Sanae Maki, Kouta Miyamoto, Junji Otsuka, Miiru Izumi, Masayuki Kawasaki…
    Citation: BMC Pulmonary Medicine 2024 24:404
  33. Progressive pulmonary fibrosis is the symptomatic, physiological, and radiological progression of interstitial lung diseases. The aim of this study was to examine the relationship between progressive pulmonary...

    Authors: Özlem Erçen Diken, Ömür Güngör and Hüseyin Akkaya
    Citation: BMC Pulmonary Medicine 2024 24:403
  34. Surgery is the main treatment option for destroyed-lung (DL) patients with life-threatening massive hemoptysis. However, short-term and long-term surgical safety and efficacy are unclear, prompting this study.

    Authors: Jing Zhao, Xiaoman Cao, Yunsong Li, Dongjie Yan, Fangchao Liu, Shuye Lin and HongYun Ruan
    Citation: BMC Pulmonary Medicine 2024 24:402
  35. This is a retrospective cohort study from a single center of Chest Medical District of Nanjing Brain Hospital Affiliated to Nanjing Medical University, Jiangsu Province, China. It was aim to evaluate the diagn...

    Authors: Qing Xie, Wei Wang, Yiling Qiu, Jiajia Sun, Huidi Hu, Jue Zou, Chunhua Xu, Qi Yuan, Qian Zhang and Yan Wang
    Citation: BMC Pulmonary Medicine 2024 24:401
  36. Acute exacerbation of fibrosing interstitial lung diseases (AE-ILD) is a serious life-threatening event per year. Methylprednisolone and/or immunosuppressive agents (ISA) are a mainstay in any regimen, under t...

    Authors: Siyu Zhan, Shuo Li, Yaoqian Cao, Dan Liu and Jing Feng
    Citation: BMC Pulmonary Medicine 2024 24:400
  37. The objective of this study was to investigate the potential association between the inflammatory burden index (IBI) and the prevalence of chronic inflammatory airway diseases (CIAD), as well as mortality rate...

    Authors: Ning Zhu, Shanhong Lin, Linfeng Wang, Xue Kong, Weina Huang and Chao Cao
    Citation: BMC Pulmonary Medicine 2024 24:399
  38. Antigen removal is a cornerstone of treatment of hypersensitivity pneumonitis (HP), but its association with transplant-free survival remains unclear. Further, HP guidelines conflict as to whether antigen remo...

    Authors: Mark J. Robertshaw, April Gorman, Craig S. Glazer and Traci N. Adams
    Citation: BMC Pulmonary Medicine 2024 24:398
  39. Plastic bronchitis is a relatively uncommon illness that has been reported in all age groups. This case report describes a specific manifestation of plastic bronchitis in two pediatric brothers influenced by b...

    Authors: Fang Jin, Lei Wu, Xiaofen Tao, Hujun Wu and Yingshuo Wang
    Citation: BMC Pulmonary Medicine 2024 24:397
  40. Prompt and effective management with maintenance therapy (single or dual bronchodilator therapy) is recommended after the initial diagnosis of chronic obstructive pulmonary disease (COPD) to maintain lung func...

    Authors: Antonio Anzueto, Sheri Rogers, Bonnie Donato, Beverly Jones, Kushal Modi, Abisola Olopoenia and Robert Wise
    Citation: BMC Pulmonary Medicine 2024 24:395
  41. Lung sound analysis parameters have been reported to be useful biomarkers for evaluating airway condition. We developed an automatic lung sound analysis software program for infants and children based on lung ...

    Authors: Hiroyuki Mochizuki, Kota Hirai, Hiroyuki Furuya, Fumio Niimura, Kenta Suzuki, Tsuyoshi Okino, Miki Ikeda and Hironori Noto
    Citation: BMC Pulmonary Medicine 2024 24:394
  42. Lung cancer, a leading cause of cancer mortality, poses significant treatment challenges. The use of immune checkpoint inhibitors (ICIs) has revolutionized therapy, but it is associated with immune-related pne...

    Authors: Fangyuan Li, Lei Zheng, Xiaoxia Xu, Jianjiang Jin, Xingxing Li and Li Zhou
    Citation: BMC Pulmonary Medicine 2024 24:393
  43. The immunologic features of nontuberculous mycobacterial pulmonary disease (NTM-PD) are largely unclear. This study investigated the immunologic features of NTM-PD using digital spatial profiling techniques.

    Authors: Jaemoon Koh, Sehui Kim, Joong-Yub Kim, Jae-Joon Yim and Nakwon Kwak
    Citation: BMC Pulmonary Medicine 2024 24:392

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.6
    5-year Journal Impact Factor: 3.0
    Source Normalized Impact per Paper (SNIP): 0.889
    SCImago Journal Rank (SJR): 0.773

    Speed 2023
    Submission to first editorial decision (median days): 24
    Submission to acceptance (median days): 138

    Usage 2023
    Downloads: 2,422,461
    Altmetric mentions: 1,250

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal